CD226 and systemic lupus erythematosus: We also assessed the association between CD226+ B cells and clinical manifestations of SLE and found that the proportion of CD226+ B cells was significantly higher in patients with renal, musculoskeletal, and/or hematological manifestations (Supplementary Table 2).